Last reviewed · How we verify
NCT04236999: YSLQQ
Unplugged, a Drug Use Prevention Program: Adaptation and Evaluation of Effectiveness Among Students in Chile
NA trial testing Yo Sé Lo Que Quiero (YSLQQ) in Substance Use in 8,880 participants. Status unknown.
31 March 2023
Quick facts
| Lead sponsor | Universidad de los Andes, Chile |
|---|---|
| Phase | NA |
| Status | Status unknown |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 8,880 |
| Start date | 1 September 2021 |
| Primary completion | 31 March 2023 |
| Estimated completion | 31 March 2023 |
| Sites | 1 location across Chile |
Drugs / interventions tested
- Yo Sé Lo Que Quiero (YSLQQ)
Conditions studied
- Substance Use — all drugs for Substance Use →
Sponsor
Universidad de los Andes, Chile — full company profile →
Who can join
Adults 10 to 15, any sex, with Substance Use. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
Substance use and drug related disorders are important public health problems. Alcohol and illicit drug use account for 5.4% of the total burden of disease and the peak has been found in early adulthood (between ages 20 and 30 years). Substance use is one of the leading problems among Chilean adolescents. One out of four 8 th to 12 th graders have smoked cigarettes in the last month. A 35.6% of students (37%, girls; 34.2%, boys) between Year 8 and Year 12 have reported any alcohol use during the last month. It is worrying that a third of 14 years old students report using alcohol in the last month in Chile. Furthermore, two out of three who are using alcohol, report regularly using 5 or more drinks in a row during the last month. Cannabis use among young Chileans has increased in recent years. Today, one out of five students between Year 8 and Year 12 referred cannabis use during the last 30 days. Almost a 20% of students in Year 8 have used cannabis in the last year. Therefore, is urgent to provide evidence-based drug preventive interventions to the Chilean population, specifically to school students, to tackle this problem and reduce the risk for a more dramatic future health scenario. The aim of this study is to develop a culturally appropriate version of the Unplugged program to the Chilean culture, and to test its effectiveness among early adolescents in low-income primary schools in Santiago, Chile. This project involves two stages: first, formative work, where the research team will review, adapt and pilot the Spanish version of the program to Chile; and second, the culturally adapted version of Unplugged program will be tested in a single-blind two-arm cluster randomized controlled trial. At the end of the intervention, investigators expect that students in schools receiving the Chilean version of Unplugged will have a lower proportion of substance use and a lower proportion of students passing from experimental use to regular use of tobacco, alcohol, and cannabis, than in control schools.
Publications & conference data
2 peer-reviewed publications reference this trial (live from Europe PMC):
-
Validation of the European Drug Addiction Prevention Trial Questionnaire (EU-Dap) for substance use screening and to assess risk and protective factors among early adolescents in Chile.
Ramírez S, Gana S, Godoy MI, Valenzuela D, et al · · 2021 · cited 9× · PMID 34634082 · DOI 10.1371/journal.pone.0258288 -
The Unplugged program in Chile ("Yo Sé Lo Que Quiero") for substance use prevention among early adolescents: study protocol for a randomized controlled trial.
Gaete J, Ramírez S, Gana S, Valenzuela D, et al · · 2022 · cited 2× · PMID 35078522 · DOI 10.1186/s13063-021-05904-3
Verify or expand the search:
- PubMed search for NCT04236999
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Substance Use
Currently open trials in the same condition.
- NCT07075081 — Gii'Igoshimong: Sitting With Your First Family · Phase 2 · recruiting
- NCT05743699 — Adaptation and Evaluation of Bright Horizons · NA · recruiting
- NCT07509853 — Integrating Sexual Pleasure Into Harm Reduction Services for Men Who Have Sex With Men and Transgender Persons Who Engag · NA · recruiting
- NCT06899308 — Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees · recruiting
- NCT07512869 — Host Led Harm Reduction Approach Among Men Who Have Sex With Men Who Engaged in Chemsex in Bangkok, Thailand: A Pre-Impl · recruiting
Other Universidad de los Andes, Chile trials
Trials by the same sponsor.
- NCT07334288 — Retrolaminar Analgesia for LuMbar Surgery · NA · recruiting
- NCT07063914 — Stratified-Care School-Based Intervention for Adolescent Suicidal Ideation · NA · recruiting
- NCT07001202 — Acceptability and Feasibility of Reframe-IT+U for Suicidality in University Students. · NA · not yet recruiting
- NCT06630143 — The Effectiveness of Combined Virtual and Clinical Simulation in Midwifery Students · NA · completed
- NCT07034235 — Effect of Wet and Overwet Dentin on the Clinical Performance of Two Universal Adhesive Systems · NA · completed
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04236999 (US National Library of Medicine, public domain)
- Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Universidad de los Andes, Chile
- Last refreshed: 10 November 2021
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04236999.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing